Home > Financial Ratios > CIPLA

CIPLA
Core EBITDA Growth

    Back to All Ratios
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -15.3313.5327.9013.836.98

What is the latest Core EBITDA Growth ratio of CIPLA ?

The latest Core EBITDA Growth ratio of CIPLA is -15.33 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-15.33
Mar202513.53
Mar202427.90
Mar202313.83
Mar20226.98

How is Core EBITDA Growth of CIPLA Trending?

Years Core EBITDA Growth % Change
Mar2026 -15.33
Negative
Mar2025 13.53
-51.51
Mar2024 27.9
101.74
Mar2023 13.83
98.14
Mar2022 6.98 -

Other Financial Ratios of CIPLA


Compare Core EBITDA Growth ratio of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹110,278.4 Cr -2.2% -6.6% -10.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics
MANKIND PHARMA ₹94,050.4 Cr -1.9% -5.8% -12.9% Stock Analytics


CIPLA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

-2.2%

-6.6%

-10.5%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses